Why the study?
To highlight using GLS rather than modified Simpson 2D-LVEF for the evaluation of long-term cardiotoxicity.
Does Global Longitudinal Strain (GLS) improve the evaluation of long-term cardiotoxicity compared to modified Simpson 2D-LVEF in patients with a history of anthracycline-based chemotherapy?
Does Global Longitudinal Strain (GLS) improve the evaluation of long-term cardiotoxicity compared to modified Simpson 2D-LVEF in patients with a history of anthracycline-based chemotherapy?
This case report highlights the utility of Global Longitudinal Strain (GLS) over standard 2D-LVEF for detecting subclinical late cardiotoxicity following anthracycline therapy.
Answers are grounded in this paper and cite their sources.
GLS may detect long-term cardiotoxicity missed by 2D-LVEF; hypothesis-generating and leaves open need for prospective validation.
Background: Cardiac toxicity is currently defined as a symptomatic decrease in Left Ventricular Ejection Fraction (LVEF) of more than 5% or an asymptomatic decrease of at least 10% to a value of under 50% in repeated evaluations on conventional transthoracic echocardiogram (TTE), as well as a Global Longitudinal Strain (GLS) value Aims: To highlight using GLS rather than modified Simpson 2D-LVEF for the evaluation of long-term cardiotoxicity. Case Presentation: The case concerns a 73-year-old female patient with a history of breast cancer chemotherapy and anthracyclines-based therapy who presented symptoms of late cardiac toxicity related to the chemotherapeutic treatment. In the following years, the patient remained asymptomatic with a 2D-LVEF of 48%, dilation of the left atrium was found, and the reservoir phase strain was severely decreased. Conclusion: The preferred method for evaluating cardiovascular complications associated with chemotherapy is the TTE, which is performed prior to the start of treatment, during therapy, and in the follow-up. Myocardial deformation as a predictor of cardiotoxicity allows the identification of subclinical heart failure.
No takes yet. Share an insight, caveat, or question.
Siller-Nava et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: